Posaconazole — Drug Intelligence | 9 EU Trials

Filter these 9 trials by condition, phase, country and more.

Open in Search →

9 Registered trials

6 Recruiting

2 Completed trials

8 Sponsors

9 Countries

Phase III

Phase II

Phase I/II

Phase IV

Phase I (FiH)

Phase III: 3 Phase II: 3 Phase I/II: 1 Phase IV: 1 Phase I (FiH): 1

Oversight events:

1 corrective measure across 1 trial

View oversight register →

Indications tested

Fungal infection 2 Aspergillus infection 1 Scedosporium infection 1 Fusarium infection 1

Sponsors using this IMP

Centre Hospitalier Universitaire De Nantes 2 Basilea Pharmaceutica International AG Allschwil 1 BeOne Medicines AG 1 Centre Hospitalier Universitaire Vaudois 1 CHRU De Nancy 1 Institut De Recherches Internationales Servier IRIS 1 Merck Sharp & Dohme LLC 1 Mundipharma Research Limited 1

All trials

9 total

PTX3 genetically stratified randomized double-blinded allocation event-driven clinical trial for antifungal prophylaxis in patients with acu… Pending

2024-517211-79-00 Phase IV 2 countries Centre Hospitalier Universitaire Vaudois
A phase 3 efficacy and safety study of fosmanogepix for the treatment of adult patients with invasive mold infections Recruiting

2024-516216-16-00 Phase III 8 countries Basilea Pharmaceutica International AG Allschwil
CPAAARI-Therapeutic efficacy comparison of a six-month treatment by itraconazole and nebulised Ambisome® versus treatment by itraconazole al… Recruiting

2024-517004-11-00 Phase III 1 country Centre Hospitalier Universitaire De Poitiers
Study of posaconazole prophylaxis in patients receiving hematopoietic stem cell allograft (allo-HSC) at high risk of invasive fungal infecti… Recruiting

2024-511507-42-00 Phase II 1 country Centre Hospitalier Universitaire De Nantes
A multi-center randomized phase II study comparing corticosteroids alone versus corticosteroids and extracorporeal photopheresis as first-li… Recruiting

2023-508614-41-00 Phase II 1 country CHRU De Nancy
Study of BGB-11417 in Patients with Myeloid Malignancies Recruiting

2023-508881-14-00 Phase I/II 4 countries BeOne Medicines AG
Posaconazole (MK-5592) IV and oral in children (less than 2 years) with IFI Recruiting

2023-505613-24-00 Phase II 3 countries Merck Sharp & Dohme LLC
Phase I/II trial of S65487 plus azacitidine in acute myeloid leukemia Ended

2023-510051-27-00 Phase I (FiH) 2 countries Institut De Recherches Internationales Servier IRIS
A Phase 3 Study of Rezafungin for Injection Versus the Standard Antimicrobial Regimen to Prevent Invasive Fungal Diseases in AdultsUndergoin… Ended

2024-514471-18-00 Phase III 5 countries Mundipharma Research Limited

Showing 1–9 of 9 trials

← All drugs A–Z